Vistagen Therapeutics (VTGN) Debt Ratio (2011 - 2026)

Vistagen Therapeutics has disclosed Debt Ratio across 12 years of filings, most recently posting 0.0 for Q1 2026.

• In Q1 2026, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (changed N/A YoY), while the FY2026 annual figure was 0.0, changed N/A from the prior year.
• Debt Ratio came in at 0.0 for Q1 2026 at Vistagen Therapeutics, down from 0.01 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.1 in Q2 2023 to a low of 0.0 in Q1 2026.
• Average Debt Ratio over 4 years is 0.03, with a median of 0.01 recorded in 2025.
• The largest YoY upside for Debt Ratio was 195.2% in 2023 against a maximum downside of 195.2% in 2023.
• Over 4 years, Debt Ratio stood at 0.03 in 2022, then jumped by 269.8% to 0.1 in 2023, then sank by 94.11% to 0.01 in 2025, then tumbled by 34.36% to 0.0 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.